Resultados de la búsqueda 1731-1740 of 16876 for polycystic ovary syndrome
Rochester, Minn. The purpose of this study is to evaluate the impact of pitolisant on Excessive daytime sleepiness in patients with Prader-Willi syndrome. A ...
The overall goal of PPMI is to identify markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability. Primary ...
... ovarian cancer. BiCaZO: A Study Combining Two ... disease cohort, both across and within tumor biomarker subgroups. ... A side effect is anything a drug does to the ...
Page 1.
In this study, we make and test preclinical models of gynecological cancers (ovarian ... Disease (CAMPERR) ... disease and recurrence. Trimethoprim ...
Cancer screening practices of individuals with Lynch Syndrome ... Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...
The goals of the study are to prospectively evaluate clinical and laboratory biomarkers of multiple system atrophy and Parkinson's disease at early clinical ...
... syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke. A ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?